Insights by Product
The automated breast ultrasound segment accounted for the largest market share over the forecast period 2024 to 2033. Compared to conventional hand-held ultrasound, ABUS devices offer higher rates of breast cancer detection because they produce detailed, high-resolution images of the entire breast. For women with dense breast tissue, where mammography alone may be less effective, this feature is very helpful. There has been a rising demand for additional imaging modalities like ABUS as knowledge of mammography's limits in detecting breast cancer in women with dense breast tissue has grown. The prevalence of breast cancer is on the rise worldwide, and there is now more focus on early diagnosis, which frequently entails additional imaging using tools like ABUS.
Insights by End Use
The hospitals segment is expected the dominate the market over the forecast period 2024 to 2033. Comprehensive breast care services, such as breast cancer screening, diagnosis, surgery, and therapy, are frequently offered by hospitals. Breast ultrasound is a crucial element of these services, which supports the expansion of this market. For patients to have access to cutting-edge technology and high-quality imaging, hospitals must invest in state-of-the-art breast ultrasound equipment. Hospitals have the funds and infrastructure to do this. Dedicated breast cancer centres with specialised care and breast imaging services have been developed in numerous hospitals. In these facilities, breast ultrasonography is frequently a crucial element.
Major players in the market